Quick Answer
Insight Molecular Diagnostics Inc. reported Operating Income Loss of -$51.12 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +16.2% in Operating Income Loss from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$1.37 million | Q2 2015: -$1.41 million | Q3 2015: -$2.41 million | Q1 2016: -$2.93 million | Q2 2016: -$2.53 million | Q3 2016: -$2.58 million | Q1 2017: -$4.53 million | Q2 2017: -$3.59 million | Q3 2017: -$6.84 million | Q1 2018: -$3.91 million | Q2 2018: -$4.23 million | Q3 2018: -$3.02 million | Q1 2019: -$4.00 million | Q2 2019: -$5.46 million | Q3 2019: -$5.26 million | Q1 2020: -$8.43 million | Q2 2020: -$8.77 million | Q3 2020: -$6.24 million | Q4 2020: -$6.27 million | Q1 2021: -$125.0 thousand | Q1 2021: -$11.36 million | Q2 2021: -$13.57 million | Q3 2021: -$13.60 million | Q4 2021: -$35.68 million | Q1 2022: -$3.02 million | Q2 2022: -$1.63 million | Q3 2022: -$1.71 million | Q1 2023: $5.85 million | Q2 2023: -$8.29 million | Q3 2023: -$6.51 million | Q1 2024: -$9.27 million | Q2 2024: -$4.63 million | Q3 2024: -$13.52 million | Q1 2025: -$6.80 million | Q2 2025: -$9.84 million | Q3 2025: -$11.05 million.
- Over the full 12 years of available data (2014 to 2025), Insight Molecular Diagnostics Inc.'s Operating Income Loss has declined by 928.0%.
- Historical annual values: Fiscal year 2025: -$51.12 million | Fiscal year 2024: -$61.04 million | Fiscal year 2023: -$25.14 million | Fiscal year 2022: -$18.00 million | Fiscal year 2021: -$53.73 million | Fiscal year 2020: -$29.71 million | Fiscal year 2019: -$22.24 million | Fiscal year 2018: -$15.20 million | Fiscal year 2017: -$18.85 million | Fiscal year 2016: -$11.14 million | Fiscal year 2015: -$8.72 million | Fiscal year 2014: -$4.97 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: